Chapter: 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Coverage and Limitations
1.4 Research Methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 EUROPE IVF MARKET ANALYSIS
3.1 Market Definition and Scope
3.2 Overview
3.3 Drivers
3.3.1 Delayed pregnancies in women
3.3.2 Supportive regulations
3.4 Restraints
3.4.1 Inadequate reimbursement policies
3.4.2 Ethical considerations
3.5 Europe IVF Market by Country
3.6 Europe IVF Market by Cycle Type
3.7 Europe IVF Market by End Users
3.8 Company Profile
3.8.1 Thermo Fisher Scientific, Inc.
3.8.2 DRK Kliniken Berlin
3.8.3 Sun Pharmaceutical Industries Ltd.
3.8.4 Cadila Healthcare Ltd. (Zydus Cadila Group)
3.8.5 LG Life Sciences
Chapter: 4 GERMANY EMBRYO TRANSFER MARKET
4.1 Overview
4.2 Germany IVF Market by Cycle Type
4.2.1 Fresh IVF cycles (non-donor)
4.2.2 Thawed IVF cycles (non-donor)
4.3 Number of Infertility Clinics, 2015
4.4 Germany IVF Market by End Users
4.4.1 Fertility clinics
4.4.2 Hospitals
4.4.3 Surgical centers
4.4.4 Clinical research institutes
4.5 Drivers
4.5.1 Subsidizing IVF treatments
4.5.2 Delayed marriages and parenthood decisions
4.6 Restraints
4.6.1 Stringent government regulations
4.6.2 Lack of availability in treatment cycles for IVF
4.7 Regulatory Issues, Legislations, and Authorities
4.8 Insurance Reimbursement Scenario
4.9 Hospitals/Clinics Profile
4.9.1 Heidelberg University Hospital
4.9.2 Klinikum Stuttgart
4.9.3 DRK Kliniken Berlin
4.9.4 University Medical Center Freiburg
Chapter: 5 FRANCE EMBRYO TRANSFER MARKET
5.1 Overview
5.2 France IVF Market by Cycle Type
5.2.1 Fresh IVF cycles (non-donor)
5.2.2 Thawed IVF cycles (non-donor)
5.2.3 Donor egg IVF cycles
5.3 Number of Infertility Clinics, 2015
5.4 France IVF Market by End Users
5.4.1 Fertility clinics
5.4.2 Hospitals
5.4.3 Surgical centers
5.4.4 Clinical research institutes
5.5 Drivers
5.5.1 Same gender adoption of IVF babies
5.5.2 Lower rates of fertility
5.6 Restraints
5.6.1 Stringent government regulations
5.7 Regulatory Issues, Legislations, and Authorities
5.8 Insurance Reimbursement Scenario
5.9 Hospitals/Clinics Profile
5.9.1 Clinique de la Muette
5.9.2 Hopital des metallurgists, hopital cochin
Chapter: 6 UK EMBRYO TRANSFER MARKET
6.1 Overview
6.2 UK IVF Market by Cycle Type
6.2.1 Fresh IVF cycles (non-donor)
6.2.2 Thawed IVF cycles (non-donor)
6.2.3 Donor egg IVF cycles
6.3 Number of Infertility Clinics, 2015
6.4 UK IVF Market by End Users
6.4.1 Fertility clinics
6.4.2 Hospitals
6.4.3 Surgical centers
6.4.4 Clinical research institutes
6.5 Drivers
6.5.1 Commercialization of three-parent IVF procedures
6.5.2 Supportive regulations
6.6 Restraints
6.6.1 Ethical considerations
6.7 Regulatory Issues, Legislations, and Authorities
6.8 Insurance Reimbursement Scenario
6.9 Hospitals/Clinics Profile
6.9.1 Lister Fertility Clinic
6.9.2 The Bridge Center
6.9.3 Chelsea and Westminster Hospital (Assisted Conception Unit)
Chapter: 7 ITALY EMBRYO TRANSFER MARKET
7.1 Overview
7.2 Italy IVF Market by Cycle Type
7.2.1 Fresh IVF cycles (non-donor)
7.2.2 Thawed IVF cycles (non-donor)
7.3 Italy IVF Market by End Users
7.3.1 Fertility clinics
7.3.2 Hospitals
7.3.3 Surgical centers
7.3.4 Clinical research institutes
7.4 Drivers
7.4.1 Growing medical tourism
7.5 Restraints
7.5.1 Ban on surrogacy
7.6 Regulatory issues, legislations, and authorities
7.7 Insurance Reimbursement Scenario
7.8 Hospitals/Clinics Profile
7.8.1 ARC-STER srl
7.8.2 RAPRUI
7.8.3 Centre for Reproductive Medicine-Napoli
Chapter: 8 SPAIN EMBRYO TRANSFER MARKET
8.1 Overview
8.2 Spain IVF Market by Cycle Type
8.2.1 Fresh IVF cycles (non-donor)
8.2.2 Thawed IVF cycles (non-donor)
8.2.3 Donor egg IVF cycles
8.3 Spain IVF Market by End Users
8.3.1 Fertility clinics
8.3.2 Hospitals
8.3.3 Surgical centers
8.3.4 Clinical research institutes
8.4 Drivers
8.4.1 Increase in the number of foreign patients
8.5 Restraints
8.5.1 Low awareness pertaining to IVF technology
8.6 Regulatory Issues, Legislations, and Authorities
8.7 Insurance Reimbursement Scenario
8.8 Hospitals/Clinics Profiles
8.8.1 IVF spain
8.8.2 Clnica EUGIN Barcelona
Chapter: 9 DENMARK EMBRYO TRANSFER MARKET
9.1 Overview
9.2 Denmark IVF Market by Cycle Type
9.2.1 Fresh IVF cycles (non-donor)
9.2.2 Thawed IVF cycles (non-donor)
9.2.3 Donor egg IVF cycles
9.3 Denmark IVF Market by End Users
9.3.1 Fertility clinics
9.3.2 Hospitals
9.3.3 Surgical centers
9.3.4 Clinical research institutes
9.4 Drivers
9.4.1 Increase in disposable income
9.4.2 Advances in IVF technology
9.5 Restraints
9.5.1 Inadequate reimbursement policies
9.6 Regulatory Issues, Legislations, and Authorities
9.7 Insurance Reimbursement Scenario
9.8 Hospitals/Clinics Profiles
9.8.1 Copenhagen Fertility Center
9.8.2 Storkklinik v/Nina Stork
9.8.3 Vitanova
9.8.4 Trianglen fertility clinic
9.8.5 NordicaDenmark, Copenhagen
Chapter: 10 RUSSIA EMBRYO TRANSFER MARKET
10.1 Overview
10.2 Russia IVF Market by Cycle Type
10.2.1 Fresh IVF cycles (non-donor)
10.2.2 Thawed IVF cycles (non-donor)
10.2.3 Donor egg IVF cycles
10.3 Russia IVF Market by End User
10.3.1 Fertility clinics
10.3.2 Hospitals
10.3.3 Surgical centers
10.3.4 Clinical research institutes
10.4 Drivers
10.4.1 Rising popularity of fertility tourism
10.5 Restraints
10.5.1 Inadequate reimbursement policies
10.6 Regulatory Issues, Legislations, and Authorities
10.7 Insurance Reimbursement Scenario
10.8 Hospital/Clinics Profiles
10.8.1 AVA-Peter Clinic
10.8.2 MD Medical Group
10.8.3 IVF Russia (The International Centre of the Reproductive Medicines)
Chapter: 11 REST OF EUROPE EMBRYO TRANSFER MARKET
11.1 Overview
11.2 Rest of Europe IVF Market by Cycle Type
11.2.1 Fresh IVF cycles (non-donor)
11.2.2 Thawed IVF cycles (non-donor)
11.2.3 Donor egg IVF cycles
11.3 Rest of Europe IVF Market by End Users
11.3.1 Fertility clinics
11.3.2 Hospitals
11.3.3 Surgical centers
11.3.4 Clinical research institutes
11.4 Drivers
11.4.1 Wide availability of reimbursements
11.4.2 Emergence of new fertility destinations
11.4.3 Changes in lifestyle
11.5 Restraints
11.6 Regulatory Issues, Legislations, and Authorities
11.7 Insurance Reimbursement Scenario
11.8 Hospitals/Clinics Profiles
11.8.1 Gynaecoloqisch Centrum
11.8.2 Centrum Voor Medische Genetica
11.8.3 Infertility-Vestliitto